Highest-materiality recent filing
DHC discloses $17.9M incentive fee for 2025, receives $27.2M dividend from AlerisLife wind-down
Incentive management fee of $17.9M incurred for 2025, payable in cash by Jan 30, 2026.
DHC terminates management agreements with AlerisLife for 116 senior living communities
116 senior living communities transitioned from AlerisLife to seven third-party managers effective December 31, 2025.
DHC issues $375M 7.25% senior secured notes due 2030; partially redeems 2026 notes
Completed private offering of $375M aggregate principal amount of 7.250% senior secured notes due 2030.
AlerisLife selling all assets, winding down by H1 2026; DHC expects net proceeds of $25-40M for its 34% stake.
Diversified Healthcare Trust sells three life science properties in San Diego for $159M
Net sales price of $159.0M for three life science properties (MUSE) with 186k rentable sq ft in San Diego.
Diversified Healthcare Trust amends bylaws and reports annual meeting results
Board adopted Fourth Amended and Restated Bylaws eliminating mandatory arbitration provisions for shareholder disputes.
Issued $940.5M senior secured notes due 2026; net proceeds ~$732M; accrues 11.25% semiannually, no cash interest unless extension.
DHC and OPI mutually terminate merger agreement; no termination fee
Mutual termination effective September 1, 2023; no termination fee payable by either party.
DHC collateral appraised value falls below credit facility threshold, triggering event of default
Appraised value of 61 medical office and life science properties declined 22% to $1.05B from $1.34B, below $1.09B threshold.
DHC: May SHOP NOI $5.8M, down 36% from Apr; debt covenant compliance unlikely before mid-2024
May 2023 SHOP occupancy 78.1%, NOI $5.8M ($11.1M below May 2019), NOI margin 6.3%.
DHC SHOP occupancy 78% in Apr, still 860 bps below 2019; CEO cites $700M debt maturity
April SHOP occupancy 78.0%, 860 bps below April 2019, 40 bps above March 2023.
DHC to merge with OPI; DHC shareholders receive 0.147 OPI shares each, OPI renamed
Merger: DHC merges into OPI; DHC shareholders get 0.147 OPI shares per DHC share; OPI renamed Diversified Properties Trust.
Diversified Healthcare Trust to Merge with Office Properties Income Trust in All-Share Transaction
DHC shareholders will receive 0.147 OPI shares per DHC share, a 20% premium to DHC's 30-trading day average closing price.
DHC Q4 2022: net loss $0.27/sh, normalized FFO $0.03/sh, SHOP occupancy up 380bps
Net loss attributable to common shareholders of $65.3M ($0.27 per share); Normalized FFO of $0.03 per share.
Facility commitments reduced from $586.4M to $450M; no further reborrowing allowed.
DHC consents to AlerisLife acquisition by ABP, agrees to tender 31.9% stake at $1.31/share
DHC owns 10,691,658 AlerisLife shares (31.9% of outstanding) and agrees to tender them into the $1.31/share tender offer.
Nasdaq warns DHC of non-compliance with $1.00 minimum bid price; 180-day cure period
Received Nasdaq notice on Jan 19, 2023: common shares bid price below $1.00 for 30+ consecutive business days.
On March 20, 2025, pursuant to the recommendation of the Nominating and Governance Committee, our Board of Trustees, or the Board, elected Alan L. Felder as an Independent Trustee with a term to expire at our 2025 annual meeting of shareholders.
Jennifer F. Francis, who is retiring from RMR on June 30, 2024, and therefore has resigned as our President and Chief Executive Officer, effective December 31, 2023.
On November 17, 2023, our Board of Trustees, or the Board, appointed Christopher J. Bilotto as our President and Chief Executive Officer, effective January 1, 2024.
On September 25, 2023, Daniel F. LePage and David A. Pierce each resigned as an Independent Trustee of our Board of Trustees, or the Board, effective that day.
On September 25, 2023, Daniel F. LePage and David A. Pierce each resigned as an Independent Trustee of our Board of Trustees, or the Board, effective that day.
Mr. Brown will replace Richard W. Siedel, Jr., who has resigned as our Chief Financial Officer and Treasurer, effective September 30, 2023.
On September 26, 2023, pursuant to the recommendation of the Nominating and Governance Committee of the Board, the Board elected Phyllis M. Hollis as an Independent Trustee to fill one of the vacancies created by Messrs. LePage’s and Pierce’s resignations, and also decreased the size of the Board from seven to six Trustees.
Also on September 26, 2023, the Board appointed Matthew C. Brown as our Chief Financial Officer and Treasurer, effective October 1, 2023.
our Board elected David A. Pierce as an Independent Trustee of our Board with a term to expire at the Company’s 2023 annual meeting to fill the vacancy created by the increase in size of our Board to seven Trustees.
Max materiality 1.00 · Median 0.40 · Most common event other_material